carteolol has been researched along with Hemangioma, Capillary in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Hemangioma, Capillary: A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, MN | 1 |
| Zhang, M | 1 |
| Xu, Y | 1 |
| Wang, M | 1 |
| Yuan, SM | 1 |
1 other study available for carteolol and Hemangioma, Capillary
| Article | Year |
|---|---|
Individualized Treatment for Infantile Hemangioma.
Topics: Administration, Cutaneous; Administration, Oral; Betamethasone; Carteolol; Female; Glucocorticoids; | 2018 |